(Q46106796)
Statements
Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy (English)
Dong Hua
27 February 2009
scientific article published on 27 February 2009